7-132133064-G-T
Position:
Variant summary
Our verdict is Benign. Variant got -10 ACMG points: 0P and 10B. BP4_StrongBP6BP7BS2
The NM_020911.2(PLXNA4):c.5574C>A(p.Gly1858Gly) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0032 in 1,613,990 control chromosomes in the GnomAD database, including 18 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (no stars).
Frequency
Genomes: 𝑓 0.0024 ( 2 hom., cov: 32)
Exomes 𝑓: 0.0033 ( 16 hom. )
Consequence
PLXNA4
NM_020911.2 synonymous
NM_020911.2 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: 1.51
Genes affected
PLXNA4 (HGNC:9102): (plexin A4) Predicted to enable semaphorin receptor activity. Predicted to be involved in several processes, including axon guidance; positive regulation of axonogenesis; and regulation of GTPase activity. Predicted to act upstream of or within several processes, including nervous system development; regulation of axon extension involved in axon guidance; and regulation of negative chemotaxis. Predicted to be located in plasma membrane. Predicted to be part of semaphorin receptor complex. Predicted to be integral component of plasma membrane. [provided by Alliance of Genome Resources, Apr 2022]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -10 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.52).
BP6
Variant 7-132133064-G-T is Benign according to our data. Variant chr7-132133064-G-T is described in ClinVar as [Likely_benign]. Clinvar id is 3041340.Status of the report is no_assertion_criteria_provided, 0 stars.
BP7
Synonymous conserved (PhyloP=1.51 with no splicing effect.
BS2
High AC in GnomAd4 at 370 AD gene.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
PLXNA4 | NM_020911.2 | c.5574C>A | p.Gly1858Gly | synonymous_variant | 31/32 | ENST00000321063.9 | NP_065962.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
PLXNA4 | ENST00000321063.9 | c.5574C>A | p.Gly1858Gly | synonymous_variant | 31/32 | 5 | NM_020911.2 | ENSP00000323194.4 | ||
PLXNA4 | ENST00000359827.7 | c.5574C>A | p.Gly1858Gly | synonymous_variant | 31/32 | 5 | ENSP00000352882.3 |
Frequencies
GnomAD3 genomes AF: 0.00243 AC: 370AN: 152162Hom.: 2 Cov.: 32
GnomAD3 genomes
AF:
AC:
370
AN:
152162
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00235 AC: 586AN: 249068Hom.: 2 AF XY: 0.00255 AC XY: 345AN XY: 135078
GnomAD3 exomes
AF:
AC:
586
AN:
249068
Hom.:
AF XY:
AC XY:
345
AN XY:
135078
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00328 AC: 4797AN: 1461710Hom.: 16 Cov.: 30 AF XY: 0.00323 AC XY: 2346AN XY: 727152
GnomAD4 exome
AF:
AC:
4797
AN:
1461710
Hom.:
Cov.:
30
AF XY:
AC XY:
2346
AN XY:
727152
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00243 AC: 370AN: 152280Hom.: 2 Cov.: 32 AF XY: 0.00222 AC XY: 165AN XY: 74456
GnomAD4 genome
AF:
AC:
370
AN:
152280
Hom.:
Cov.:
32
AF XY:
AC XY:
165
AN XY:
74456
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
3
AN:
3478
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Likely benign
Submissions summary: Benign:1
Revision: no assertion criteria provided
LINK: link
Submissions by phenotype
PLXNA4-related disorder Benign:1
Likely benign, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | May 26, 2021 | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at